# Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives

> **NCT01750476** · — · TERMINATED · sponsor: **Thomas Cherpes, DVM, MD** · enrollment: 7 (actual)

## Conditions studied

- Initiation of Oral Contraception (OC)
- Initiation of Depo-Provera (DMPA)
- Initiation of Mirena (LNG-IUD)

## Interventions

- **DRUG:** Mirena
- **DRUG:** Oral contraception
- **DRUG:** Depo-Provera

## Key facts

- **NCT ID:** NCT01750476
- **Lead sponsor:** Thomas Cherpes, DVM, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12
- **Primary completion:** 2013-04
- **Final completion:** 2013-06
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** PI and lab have re-located study to The Ohio State University
- **Last updated:** 2014-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01750476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01750476, "Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01750476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*